Fatima_2023_Arch.Pharm.(Weinheim)__e2300384

Reference

Title : Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies - Fatima_2023_Arch.Pharm.(Weinheim)__e2300384
Author(s) : Fatima B , Saleem F , Salar U , Chigurupati S , Felemban SG , Ul-Haq Z , Tariq SS , Almahmoud SA , Taha M , Shah STA , Khan KM
Ref : Arch Pharm (Weinheim) , :e2300384 , 2023
Abstract : Fatima_2023_Arch.Pharm.(Weinheim)__e2300384
ESTHER : Fatima_2023_Arch.Pharm.(Weinheim)__e2300384
PubMedSearch : Fatima_2023_Arch.Pharm.(Weinheim)__e2300384
PubMedID: 37806747

Related information

Citations formats

Fatima B, Saleem F, Salar U, Chigurupati S, Felemban SG, Ul-Haq Z, Tariq SS, Almahmoud SA, Taha M, Shah STA, Khan KM (2023)
Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies
Arch Pharm (Weinheim) :e2300384

Fatima B, Saleem F, Salar U, Chigurupati S, Felemban SG, Ul-Haq Z, Tariq SS, Almahmoud SA, Taha M, Shah STA, Khan KM (2023)
Arch Pharm (Weinheim) :e2300384